It found that in PC-3 and LNCaP cells, two typical prostate cancer cell lines, Nav1.6 and Nav1.7 were highly expressed with their mRNA levels 6–27 times higher in PC-3 and LNCaP than in normal or BPH samples. This evidence concerns the gene SCN9A and prostate carcinoma.